Clinical Research Article
 

The Thoracic Veins and Ablation for Atrial Fibrillation
Jothi Kanagalingam, Samuel J. Asirvatham
Cardiovascular Pathology Department, Johns Hopkins Medical Institution – Baltimore, Maryland, Division of
Cardiovascular Diseases, Department of Medicine and Department of Pediatrics and Adolescent Medicine - Mayo
Clinic, Rochester, Minnesota

Abstract

The last decade has witnessed a revolution in the management of paroxysmal atrial fibrillation (PAF).
Fundamental to these changes has been the understanding that the thoracic veins, which include the pulmonary
veins and superior vena cava, represent the initiating trigger site for atrial fibrillation (AF). In this article, we
discuss the rationale for ablation around the thoracic veins for managing patients with PAF.
We describe a selection of appropriate patients for venous isolation procedures, particularly in the context of
the Indian subcontinent and then go on to explain ablation approaches that optimize safety and efficacy with
the complex procedures.
Although this article is targeted for interventional electrophysiologists beginning these procedures the rational,
initial patient selection for referral and follow up of post ablation patients will be relevant to all practicing
cardiologists.

Key words:pulmonary veins, superior vena cava, vein or Marshall, radiofrequency ablation, paroxysmal atrial
fibrillation, atrial fibrillation and chronic atrial fibrillation.

Introduction


Radiofrequency ablation procedures have become an
important treatment option fort patients with symptomatic
drug refractory Atrial Fibrillation (AF). Intrinsic to the
development of this major advance has been two important
realizations. First, AF is not a homogenous disorder but
rather consists of paroxysmal (trigger related) and chronic
(substrate) forms of AF and secondly appreciating the role of
the thoracic vein in initiating AF1,2.
For years, AF was thought to be a manifestation of diseased
atrial myocardium3,4. Multiple wavelets of reentry that were
meandering and created a chaotic arrhythmia without a
discrete triggering source were until recently the accepted
understanding of the disorder5-7. In the last dozen years, once
it was realized that PAF is a disorder caused by discrete
initiating triggers or arrhythmia, the potential for treating this
disease by invasively targeting the initiating sites was quickly
realized and rapidly adopted6-9.
While chronic AF still remains a complex disease where
abnormal substrate (atrial myocardium) is paramount in
pathogenesis, the emphasis for management of PAF are the
triggers that initially caused the change from sinus rhythm to
the tachyarrhythmia10

 

The seminal observation6,7 that the pulmonary vein can trigger AF put into clinical practice suggestions of earlier investigators and have allowed us to appreciate the role of classic venous structures in the etiology of AF better . While the pulmonary veins are clearly the most important venous figures for AF, other thoracic veins including superior vena cava (SVC), atrial tributaries of the coronary sinus and the coronary sinus itself have all been demonstrated to be potential triggers for AF8,11,12.
In this article, we briefly discuss the collection of the most appropriate patients for venous isolation procedures and provide guidelines for the interventional ablationist to electrically isolate these veins. A cornerstone to understanding the correct technique in isolating the pulmonary veins (PV)
is an appreciation of the regional anatomy and the genesis of the typical pulmonary vein electrograms (PV potentials).
Equally important in appreciating the morphological features of the complex vein is a thorough understanding of what constitutes the PV ostium. Finally, and perhaps most importantly, a discussion on methods to minimize the welldescribed complications associated with these procedures is outlined. A brief discussion of the roles of cardiac imaging in optimizing results with the ablation management of PAF is included.

Correspondence: Samuel J. Asirvatham,Division of Cardiovascular Diseases,Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905
E-mail:asirvatham.samuel@mayo.edu

Indian Heart J. 2009; 61:163-172
 
163
Jothi Kanagalingam et al
 
 

Who Is the Ideal Patient for the Invasive Management of Atrial Fibrillation? The pathogenic factors responsible for chronic AF are vastly different from PAF, but care must be taken in directing patients for the isolation procedure. The patients who benefit the most from PV and other venous isolation procedures are the patients with repeated but self-terminating episodes of AF. These patients often have a structurally normal heart, are young and have only mild or moderate enlargement of the left atrium(LV)13. While hypertension and diastolic dysfunction may be present in patients with PAF, the severe comorbidities that accompany chronic AF such as ventricular dysfunction, congestive heart failure and advanced diabetes are usually absent. Patients with chronic forms of AF may benefit from venous isolation; however, very often, additional treatment that would include extensive linear ablation to modify the abnormal atrial substrate, continued antiarrhythmic drug therapy along with possible placement of antitachycardia pacemakers to address the main typical atrial flutters is required. Even when a primary substrate mediates the approach like linear ablation, ablation of fragmented atrial electrograms or targeting the retroatrial ganglionated plexii, knowledge of the regional anatomy and addressing the (PVs) remain critical14,15. It should be emphasized that although patients with PAF tend to be the same patients with structurally normal hearts, normal size atria and of a younger age but the critical feature in assessing which patients are likely to benefit from pulmonary venous isolation which is the paroxysmal nature of the arrhythmia itself16. The fact that the arrhythmia self terminates, is powerful evidence of the lack of severe substrate abnormalities and thus
they enhance the etiological role of the initiating sites for arrhythmia. Accurate selection is particularly important in the Indian subcontinent given the limited number of centers, procedures available and potentially prohibitive costs associated with repeated and failed procedures. The criteria to identify the best patient for these procedures are summarized in Table1 given below17,18.

Table 1:The Ideal Candidate for Thoracic Vein
Isolation in Managing Atrial Fibrillation
1. Paroxysmal atrial fibrillation
2. Structurally normal heart
3. Younger age
4. Significant and lifestyle altering symptoms despite
attempts at medical therapy
5. Absence of requirement for cardioversion
6. Absence of severe atrial enlargement
7. Relatively recent onset of symptoms (< 5 years)

 

PULMONARY VEIN ISOLATION
Once the appropriate patient has been recognized with symptomatic PAF despite medical therapy, the next step is knowing how best to electrically isolate the PV. To do this, the operator must be fully conversant with understanding the PV potential and the location of the PV ostium. Once this is done, the actual technique of the ablation must be known, specifically how to validate the PV potentials and to know when the procedure is complete, i.e. entrance block into the vein has occurred.
THE PULMONARY VEIN POTENTIALS
The bipolar electrograms from an electrode tipped catheter placed with the PV produces a characteristic electrogram (Figure 1). In patients with AF, three distinct components for the electrogram are noted. First, a far-field component that represents atrial activation is followed by a period of electrical silence (isoelectric period) and then a sharp distinct nearfield electrogram resulting from PV myocardial activation is identified. The far-field component may be the right or LA, depending on which PV is being mapped and the near-field component is almost always a result of conduction into the PV from the LA (see below). The PV musculature itself is a complex layer of atrial myocardium that extends into the PV for variable lengths. An important part of this complex electrogram is the isoelectric period. While the exact reason for this delay in activation is not completely understood, it importantly correlates with the anatomic ostium of the vein. Thus, the site of electrical delay into the vein or with ectopy out of the vein corresponds to the ostium of the vein. Studies have shown that the PV that are most arrhythmogenic and exhibit the greatest amount of ostial delay (> 30 to 40 ms)8.

  Figure 1 A major advance in ablation for paroxysmal atrial fibrillation
is the understanding that the electrogram obtained in the pulmonary vein
was characteristic and was normal in patients with atrial fibrillation even
when they are in sinus rhythm. A characteristic electrogram seen in
arrhythmogenic veins. Typically noted is the initial far-field activation of
the atrium followed by a period of electrical silence in the region of the
ostium and then the spike-like pulmonary vein potentials (PVC).

 

164
 
Indian Heart J. 2009; 61:163-172
 
The Thoracic Veins and Ablation for AF
 

The key portion of the PV isolation procedures is the circumferential ablation, in the atrium proximal to the ostium of the PV that converts this ostial delay to complete conduction block and thus the abolition of the PV potential. Although the exact pathology of the ostium is unknown, an abrupt change in myocardial fiber orientation, fibrosis from mechanical wear and tear or other cardiac diseases, interdigitation of venular smooth muscles with cardiac syncytial muscle and possible nodal remnants located near the ostia have been thought to be the reason.

THE PULMONARY VEIN OSTIUM


An important conundrum exists with regard to the PV ostium19. On the one hand, it is critical for electrophysiologist to know exactly where the PV ostium is located since ablation within the vein results in PV stenosis without getting rid of the entire arrhythmogenic substrate. On the other hand, even with an autopsied heart, it is not possible to know exactly where the PV ends and the LA begins. Usually, four PVs (two to eight veins) drain into the posterior wall of LA. The actual venoatrial junction may in some cases be an abrupt transition from a cylindrical vein to the more bulbous atrium (often the case with the left sided veins), but other times, the transition is extremely gradual with a funnel-like opening or a cloacal entrance that in turn is the drainage site for more than one vein (Figure 2). Since the exact anatomic location of the ostium is difficult to know, electrophysiologists should be aware of this difficulty and err on the side of ablating more proximally into the LA. Imaging studies, as well as electrical maneuvers, can aid the electrophysiologist in approximating the site of the PV ostium.

CT/MRI/ANGIOGRAPHY


Commonly used methods to appreciate PV anatomy and aid the ablation procedure include CT scanning, MRI, as well as retrograde pulmonary venography performed during the ablation procedure. CT or MRI have the advantage of giving exquisitely detailed anatomic information on the number and morphology of the PVs. The methods of branching aberrant or unusually positioned veins as well as complex drainage pattern can all be viewed by the operator prior to manipulation in the patient’s LA. A major disadvantage of these off-line imaging resources, however, is that changes in left atrial volume (LAV) and the relative anatomy of the atrium occur during ablation procedures as a result of dehydration or

.
Figure 2: The region, anatomy and structure of the pulmonary vein are variable. In this example a large single ostial side of the vein is noted and the anterior wall of this vein is just apposed to the posterior wall of the left atrial appendage near the ostium
 
 
induced tachyarrhythmia. Thus, methods to integrate previously obtained CT scans (merging technology) with real-time fluoroscopy, as well as ultrasound, are being evaluated. The operator must remember that even with the excellent images seen with today’s CT or MRI scans, the ostium still has to be approximated, especially when a gradual, tapering funnel-like entrance to the vein, as is often seen with the right upper PV exists. CT and MRI are also useful in identifying the relationship of the LA and PVs with potential sites of collateral damage with ablation such as the esophagus, the descending aorta and the left pulmonary artery (PA). PV angiography can be performed either antegrade (injection into the PA with levo-phase imaging) or retrograde (more commonly retrograde PV angiography is performed). Here, one of the transseptal sheaths or an end-hole balloon occlusion catheter is placed at the ostium of the PV, and contrast is injected. The balloon is then deflated while cine fluoroscopy is continued to image the ostium. The advantages of venography are that it can be performed with catheters in place to understand the relationship of catheters with anatomy. Venography can also be repeated when there is some question of spasm, dissection, or stenosis. The main disadvantages of retrograde pulmonary venography are the needs to use contrast, the potential that injection itself may affect the vein, and the possibility that an entire PV may not be recognized being present since the vein has to be entered to inject dyes. Pulmonary venography can also be misleading when there are complex branching patterns in the vein. A very common error for ablationists early in their practice is to mistake a

 

Indian Heart J. 2009; 61:163-172
 
165
Jothi Kanagalingam et al
 
 

branch point of small venous tributaries as being the entrance of the PV into the LA. Intracardiac Ultrasound The linear phased-array imaging with the probe placed in the right atrium via a femoral vein can be very useful for online imaging during PV ablation procedures20,21. Intracardiac ultrasound using this technique can also aid transseptal puncture, assess for the development of thrombus and quickly identify potential causes of hypotension including cardiac perforation20. One of the most important uses for this technique, however, is to visualize in real-time the PV ostial region and assess where the ablation catheter is in relation to the vein. The intracardiac ultrasound probe is placed close to the fossa ovalis, and the image adjusted for that the lateral wall of the LA and PV can be visualized. With clockwise rotation, the right-sided PV can be seen oblique or short axis, where as the left sided PVs are seen in their long axis with slight counter clockwise rotation. Doppler evaluation can assess pulmonary venous flow to quickly detect spasm or thrombus formation as well as dissection.

ELECTRICAL METHODS TO IDENTIFY
THE PULMONARY VEIN OSTIUM


The use of endocardial pacing techniques can be very helpful in identifying the “electrical ostium” of the PV22. When a circumferential mapping catheter is placed inside the vein, the classical PV potential is seen. If a mapping catheter is then used to pace in the LA, left atrial signal is captured and the PV potential is easily visualized. However, when pacing inside the vein, the PV potential is captured, and because of the saturation from the pacing artifact, the pulmonary vein potential is no longer seen. The concept of pacing near the PV is described below. Thus, prior to delivery of ablation energy if the operator is concerned whether the ablation catheter is inside the vein, pacing can be initiated. If the PV potential is “captured”, then the catheter is in the vein. With continued pacing, the catheter is dragged back, and when the PV potential is “released”, then the ostium has been crossed and the catheter is now in a safe location in the atrium for ablation to proceed.

ISOLATION OF THE PULMONARY VEINS


Radiofrequency ablation to isolate the PV involves the placement of ablative lesions in the LA proximal to the ostia of the PV. This has been variably referred to as periostial ablation or wide area circumferential ablation. Regardless of the name tag, ablation is in the LA and not at the ostium or in the PV. Variations in the technique based on the use of mapping systems or whether individual veins are isolated exist, but the essentials of the

procedure are constant. With radiofrequency ablation, the eventual circle of ablative lesions can be placed around each vein or the right-sided veins and left-sided veins as units. The exact location of these lesions should not vary whether ultrasound, three-dimensional mapping or simple fluoroscopy is used. The ablation lesion should never be placed in the PV but exactly how far back in the atrium they are placed may vary from operator to operator. Lesions placed much proximally to the ostium in the LA have a disadvantage in that the myocardium may be thicker and difficult to ablate and the circulation ablation lesions may be so close to each other or to the mitral annulus so as to leave a small conducting isthmus that promotes reentrant atypical flutters. When large, wide area lesions have been found necessary and accomplished most ablationists will connect the circles with
linear ablation and also anchor the left-sided circle to the mitral annulus to prevent such proarrhythmic flutters. Alternate energy sources including cryoablation either delivered in a point-by-point manner or as part of circumferential balloon based ablation are being investigated, but the methods described below in terms of assessing endpoints are the same even when these approaches are used (Figure 3).
Potential difficulty with ablation
Anatomic locations frequently creating difficulty during circular and wide area ablation include a region between the anterior wall of the left-sided PV and the left atrial appendage (LAA). This so-called
 
 
 
Figure 3: An ideal result from circumferential pulmonary vein isolation, ablation has been carried out in the atrium. A characteristic pulmonary vein potential is noted on the circumferential mapping catheter (Lasso). Following the first two episodes of coronary sinus pacing there is an abrupt loss of the pulmonary vein potential. Note that there was no diminution of the pulmonary vein electrogram amplitude prior to loss. This is the expected result since
ablation is not being done within the pulmonary vein. (P1 Art - arterial monitor; II and V1 – EKG lead; HRA – high right trial
catheter; Lasso 1, 2 – Lasso 10, 1 – widely spaced circumferential mapping catheter placed in a left sided pulmonary vein; ABL d – ABL p – ablation electrodes distal and proximal; CS 1, 2 – CS 17, 18 – high polar coronary
sinus electrodes with CS 17, 18 being placed at the ostium).
 
166
 
Indian Heart J. 2009; 61:163-172
 
 
The Thoracic Veins and Ablation for AF
 
Table 2. Steps in the Pulmonary Vein Isolation Procedure
 
endocardial LA ridge occurs just endocardially to this epicardially located left (SVC) in the fetus. Sometimes, ablation may be performed on either side of the ridge; i.e. within the LAA appendage or just at the ostium of the PV to accomplish isolation. When ablating inside the vein or at the ostium, power should be limited to 25 Watts and the temperature not exceeding 47 to 50 degrees when using a standard 4-mm or 5-mm tip temperature controlled catheter. Another area of difficulty is on the roof of the left atrium near the right-sided PV. Here, the musculature may be quite thin, and there is an increased risk of perforation, particularly when a stiff catheter is being used by an inexperienced operator. When using an open irrigation catheter,
temperature control is no longer valid and power control should be
used with appropriate changes in the irrigation drip rate always keeping in mind that the local atrial electrogram should diminish as an endpoint to each ablation site rather than empiric time limit cut off. Even when three-dimensional mapping systems are used, one should not rely on the ablation “dots” as to know where successful ablation has occurred23. The local diminution of the atrial electrogram either resulting in fragmentation or double potential should be used to signify complete ablation at a given site11, 14, 24. Regardless of the catheter or imaging system used, the important principles of circumferential mapping in the vein, validation of the pulmonary vein potential and recognition of entrance and exit block are key.
Indian Heart J. 2009; 61:163-172
 
167
Jothi Kanagalingam et al
 
 
 
Figure 4: The pulmonary vein potential, when obtained during mapping
in the pulmonary vein, is not always straightforward to analyze. In this
example, a multi-component signal, one of which represents pulmonary
vein activation, is noted. An accurate knowledge of region of anatomy and
the use of various pacing maneuvers will help sort out the origin of each
of these signals expeditiously.
 
CIRCUMFERENTIAL MAPPING
Most ablation laboratories use a circumferential mapping catheter (Lasso™) to assess for pulmonary vein potentials and to determine when entrance block has occurred. When using a circumferential mapping catheter in the PV, one must chose between a catheter with closely spaced bipolar electrograms or widely spaced bipolar (unipolar Lasso) electrodes. Widely spaced electrodes do not require exact sizing within the vein and will pick up the PV potentials even when the catheter size is small (Figure 4). The disadvantage is that non-pulmonary vein potentials (contaminant far-field electrograms) will also be recorded. Closely spaced bipolar systems will not pick up the far-field signals as much but if not exactly sized, may miss PV potentials, particularly in redo procedures. While there is no “correct” system to use, the authors’ preference is to use the widely spaced electrodes since pacing maneuvers (described below) can readily distinguish between actual PV electrograms and contaminate far-field signals, but if undersized and the PV is not seen with the bipolar system, then there is no maneuver changing the catheter to make these signals apparent. Some concepts with regard to circumferential mapping should
be clearly understood by the ablationist:
1. Both far-field and near-field electrograms will be seen on the circumferential catheter with larger far-field electrograms being noted when the catheter is positioned closer to the ostium.
2. The PV activation sequence is of little meaning with circumferential mapping unless one is certain that all of the electrodes along the circumference of the catheter are equidistance from the ostium (perpendicular to the long

axis of the vein). This is because earlier activation will always be seen at electrodes closer to the ostium and if the circumferential catheter is tilted inside the vein, then a false impression of a connecting or early site of activation will be given by looking at the electrodes that are closer to the ostium compared to those that are tilted far within. 3. One must have a qualitatively different signal on the ablation catheter than on the mapping catheter. That is, on the ablation catheter the near-field electrogram will be earlier and representing the LA myocardium that is to be ablated. In contrast, on the mapping catheter the near-field signal is the PV potential and occurs after the far-field atrial signal and ostial delay explained above.

VALIDATION OF THE PULMONARY VEIN
POTENTIAL


As described above, most cases of the PV potential is easy to recognize. However, following ablation and with certain anatomic variants (anterior vs. superior vein very close to the appendage), it can be exceedingly difficult to know whether the PV is still being recorded following ablation on the circumferential mapping catheter. Misdiagnosis can lead to excessive ablation that is unnecessary and potentially associated with complications, and if the PV potential that is actually present is not recognized, then inadequate ablation may occur, potentially giving rise to recurrent arrhythmia. When a catheter is placed in the PV in addition to the atrial farfield signal and the PV potential near-field signal, other complex electrograms generated from neighboring structures can also be seen. When the catheter is placed in the left-sided vein, contaminant signals from the LAA, vein of Marshall, adjacent PV, etc. may all be recorded. Similarly, when a catheter is placed in the right upper vein in addition to the signals from the LA and PV musculature, electrograms from the right atrium (RA), SVC and adjacent PVs may be found. Sometimes, despite experience and caution, inadvertent ablation within the PV occurs and these signals become fragmented, further complicating the issue. Some relatively straightforward pacing maneuvers, once understood and mastered, can easily identify what is and what is not the PV potential. Peri-vein pacing The concept underlying this technique is that when complex electrograms are found and pacing is performed at an anatomic site responsible for one of those electrograms, that component will be advanced or pulled towards the pacing stimulus artifact. After a mapping catheter is placed in the left upper PV and three component signals are found, one may be of the LA, another the LAA and yet another is the PV potential. If LA pacing is performed close

168
 
Indian Heart J. 2009; 61:163-172
 
The Thoracic Veins and Ablation for AF
 

to the PV but not within the vein, then the left atrial component of that signal will be advanced towards the pacing stimulus with little or no effect on the PV potential and contaminating LAA signals. On the other hand, if the pacing site is now in the LAA, then the component of the complex electrogram that represents far-field activation of the LAA will now be advanced towards the pacing stimulus. By understanding the anatomy and the principle of peri-vein pacing, the exact origin of each signal can be easily identified. It should be noted that the coronary sinus pacing or right atrial pacing are not a substitute for pacing the LA near the PV to advance the LA component. This is because of the anatomic distance of these pacing sites from the PV. Intra-vein pacing Here, the concept is that when the pacing catheter is now placed within the PV, the only electrogram that will be advanced is PV potential itself. While this maneuver directly allows recognition of the potential we are most interested in, namely the PV potential, the problem is that often high output pacing is required to capture the myocardium, and this may result in far-field capture of anatomic neighbors such as the LAA. A variation of intra-vein pacing is described above in electrical methods to identify the PV ostium.

IDENTIFYING ENTRANCE BLOCK


The primary endpoint for PV ablation procedures is the electrical isolation of the PV, which is identified by entrance block (failure of propagation of LA activation into the PV). It this is mandatory that the ablationist understand that loss of PV potential should not result from ablation if the PV myocardium and fragmentation is a signal, but rather from entrance block. Thus, as ablation is performed in a periosteal manner as described above, one should see a gradual diminution of the far-field atrial signal, and progressive delay in activating the PV potentials, but importantly no change in the amplitude of the pulmonary vein potential itself. These desired changes cannot be over emphasized as to their significance. Sometimes, gradual diminution of the PV potential may be observed – so-called "melting away of potentials". This is a highly undesirable effect as it reflects ablation within the PV itself. Ideally, there should be progressive delays and eventual
loss of conduction into the vein signified by the loss of the PV potentials. The far-field LA signals change very little in this sequence. If a marked changed in these signals is noted, the catheter may have moved deep into the PV. Typically, circumferential or near circumferential ablation is required to get entrance block. If an operator notes that he/she gets entrance block repeatedly with just one or two burns, it is certain that ablation is being performed into the PV and the operator has mistaken a branch of the pulmonary vein for the main PV itself.

EXIT BLOCK
Exit block is defined as pacing and capture of the PV musculature

but without conduction from the vein to the rest of the atrium. While exit block is closer physiologically to the desired results of preventing arrhythmogenic activity from the PV to exit to the atrium and produce AF, this is difficult to demonstrate in many cases. Often, pacing within the PV, particularly if there is a relatively short sleeve of musculature in the vein, will result in noncapture of the local myocardium, and exit block can not be demonstrated. Sometimes, simple mechanical catheter trauma or spontaneous ectopy with resulting exit block can be easier to demonstrate. With both entrance and exit block, it is important to recheck for these parameters about a half an hour following ablation around the vein with the use of isoproterenol. A recurrence of conduction into the outside of the vein should be addressed by repeating a circumferential ablation procedure often with identifying a gap in the circular series of ablation points.

NON-PULMONARY VEIN FOCI


Thoracic vein triggers for PAF are not confined to the PVs. Well-established alternative trigger sites include the atrial myocardium within the SVC and the vein of Marshall. In addition, the electrical sleeves around the coronary sinus and electrically active connections between the PVs or between the right atrium and right upper PV may require targeted ablation. Superior vena cava isolation Atrial myocardium extends into the SVC for various lengths12,27 this may be continuous with the musculature with the Azygos vein. If ectopy or other arrhythmogenic potentials similar to that seen on the PV are noted with a circumferential mapping catheter placed within the SVC, then circumferential isolation of this vein can be undertaken. The technique is identical to that described for PV isolation except for some important differences (Figure 5). First, the phrenic nerve often lies in the posterior (posterolateral or posteromedial course) aspect of the SVC – RA junction. To avoid damage to the phrenic nerve during ablation, pacing at an output of 5 to 10 milliamp should be performed at all sites prior to delivering radiofrequency energy. The ablation circle can be adjusted to avoid damage to the phrenic nerve in most cases and yet achieve entrance block with loss of the superior vena caval potentials. In some situations however, complete isolation is not possible with this technique because of phrenic nerve stimulation when attempting the preablation pacing. Here, the technique of pacing within the SVC while cryoablating at the ostium can be performed28.
Vein of Marshall Ablation Similar to the approach for the SVC, arrhythmogenic potentials with evidence of ostial delay are found when mapping in the embryological remnant of the left superior vena cava; i.e. the vein of Marshall (Figure 6). In some cases,

Indian Heart J. 2009; 61:163-172
 
169
 
Jothi Kanagalingam et al
 
 
ectopy of monomorphic atrial tachycardia initiating recurrent AF can be tracked to originate in this venous structure11, 29. Ablation to isolate this vein can be undertaken but the procedure is significantly different because of the lack of ostial connections to the LA. The vein may be ablated directly at its ostium via the coronary sinus. Extreme care is needed with this approach to make sure that there isn’t inadvertent ablation of the circumflex coronary artery. To do this, the right anterior oblique projection should be viewed continuously and the ablation electrode should be directed atrial to the main body of the coronary sinus. Another approach is to ablate on the endocardial ridge which always lies in exact apposition to the vein of Marshall between the left-sided PVs and the LAA. Transmural ablation at this site will typically ablate vein of Marshall potentials as well. At times, the vein of Marshall may need to be ablated even when ectopy or arrhythmia is not arising from this vein. This is because the vein may form a “bypass” conduit between the PVs and the coronary sinus. When this occurs, it is impossible to electrically isolate the veins by ablating periosteally on the LA
side. This situation, once ascertained, can be found by ablating as described above29. Right atrial to right superior pulmonary vein connections In most hearts, there is an anatomic cleavage plane between an anterior wall of the right-sided PVs and the posterior wall to the SVC and RA (Waterson’s sulcus). In some patients, there is an electrically active myocardial connection that breaks this vein and directly connects the right PV to the RA. Suspicion to this possibility arises when there is inordinate difficulty in isolating the right upper vein and when pacing the RA, even at low output, the PV potential is captured. Further evidence for such connections will be noted when mapping within the PVs since the early activation site will not be at the ostium but rather deeper within the vein. Various approaches can be used to solve the problem including direct ablation of the connection within the vein. The authors’ preference is to pace within the PV and map the site of earliest activation in the RA. The right atrial early activation site is then targeted for ablation typically resulting in conduction block into the vein assuming that left atrial circumferential ablation has already been carried out.
AVOIDING COMPLICATIONS
Since AF itself is not a major cause of mortality, it is vital that any procedure performed for AF should be as safe as possible and not make the cure worse than the disease. AF ablation can and is performed safely in the majority of patients. However, very serious and potentially life-threatening complications occur in 2-5% of patients. While some of these complications are germane to any type of ablation procedure, we will briefly
 
Figure 5: This shows circumferential mapping in the superior vena cava approximately 2 cm distal to the right atrium – superior vena caval junction. Note a pulmonary vein like potential is noted giving coronary sinus pacing. The nearfield electrograms are tied components probably resulting from some signals related to the Azygos vein. Note on the third beat the venous potentials occur early. This is a result of coincidental simultaneous ectopy from the vein with coronary sinus pacing.
 
 
 
Figure 6: Dissection showing the left lateral view of the left atrium, left ventricle, left sided pulmonary vein and the left atrial appendage. The vein of Marshall has been opened and the lumen exposed. Note the constant location of the structure between the left sided pulmonary vein and the posterior wall of the left atrial appendage. (LAA – left atrial appendage, LIPV – left inferior pulmonary vein)
 
 

describe a few that are peculiar to AF ablation.
PULMONARY VEIN STENOSIS


Clinically significant narrowing or complete occlusion of the PV occurs in 1-8% of PV isolation procedures30. The primary reason for PV stenosis is inadvertent ablation within the PV (Figure 7). Any method to isolate the PV should have the site of ablation energy delivery in the LA and not in the PV. CT and/or ventilation profusion scan performed prior to and three months after ablation will readily recognize this complication. When up to 50% narrowing in the vein is seen without associated symptoms, observations with repeat CT scan is reasonable. If symptomatic

170
 
Indian Heart J. 2009; 61:163-172
 
 
The Thoracic Veins and Ablation for AF
 

narrowing is noted with a clear correlation of narrowing with complaints such as shortness of breath, hemoptasis and cough, then PV angioplasty or stenting should be performed. Unfortunately, there is a greater than 50% recurrence rate of stenosis following PV dilation and stenting procedures. At
times, there may be mild narrowing of the PV with unclear symptomatology. In these situations, quantitative ventilation profusion scanning, along with exercise testing to look for oxygen desaturation, can clarify the issue.
Atrial-esophageal Fistula Formation
This is a well-recognized and unfortunate result of some AF ablation procedures. The anterior wall of the esophagus is immediately related to the posterior, part of LA at variable locations and is at times posterior to the PV ostia. The course of the esophagus is typically oblique but variable from patient to patient and in a given patient varies with peristalsis and patient position. The major symptoms and signs of this dreaded complication are unexplained bacteremia, air found in the LA during echocardiography, dysphasia, hematemesis and rapidly progressive endocarditis. Terminal events may include air embolization to the brain or stroke from embolized vegetation. Immediate recognition of this condition is the only way to avoid certain death. As soon as the possibility is considered surgical exploration or stenting of the esophagus must be immediately offered as options. Avoiding this complication is best done by limiting power delivery in the posterior part of atrium. Intracardiac echocardiography can visualize the oblique sinus and the anterior wall of the esophagus (Figure 8). Changes in echo texture at these locations should immediately result in cessation of ablation energy delivery. Remembering to stop energy delivery whenever the atrial electrogram diminishes (rather than waiting for some preset empiric period of time) will likely help avoid this issue. Some operators will place a temperature probe in the esophagus, and clearly if the temperature rises, energy should be turned off. However, significant damage to the wall of the esophagus may have already occurred before the endoluminal temperature
measured by such probes increases.
THROMBOSIS AND STROKE


A devastating complication of LA ablation, which presently does not have a definite method of prevention, is thrombus formation and stroke. While anticoagulation with heparin is the main method of preventing thrombosis, it is not always sufficient. Heparin needs to be initiated early and experienced operators will fully heparinize with a target aCT of > 300 seconds even prior to transseptal puncture. At the very least, as soon as transseptal puncture is done, complete heparinization is mandatory. Other techniques include careful sheath management

 
 
Figure 7: Pulmonary vein stenosis is an entirely avoidable complication of atrial fibrillation ablation based on the understanding of ostial anatomy. Regardless of techniques used ablation must never be performed within the pulmonary vein. This is because endothelial separation occurs without compensatory dilation resulting from ablation of the myocardium as occurs in the left atrium or close to the ostium of the pulmonary vein.
 
with a continuous flush and avoiding over sizing the sheath relative to the catheter diameter. Flushing with saline through the sheath or pulling the sheath back to the RA once the catheters are advanced to the LA are done by some operators to further minimize the risk of stroke25, 31. None of these measures, however, will impact coagulum formation. Coagulum occurs as a result of direct heat related denaturation of fibrinogen to fibrin. This is a thrombin independent process and thus cannot be impacted by heparin – an antithrombin aid. One experimental technique to try to reduce coagulum formation involves the concurrent application of negative direct current charge on the electrode surface while ablating32. If thrombus is recognized, the authors’ preference is to place a vascular protection device into the carotid artery and then physically suction or snare large thrombi back to the right-sided circulation. Thrombolysis or surgical clot removal have also been used at some centers.
SUMMARY
In this article, we have reviewed patient selection and technique of ablation targeting the thoracic vein, which have now been established as the trigger site in the majority of patients with PAF. High success with relatively low complication rates can be obtained with PV isolation, and an ablationist should aim for 70% or greater success rate with a < 2% chance of significant complications. In addition to patient selection, patient education
to cultivate realistic expectations of the procedure and rationale for performing are important. The procedure is not performed to save lives or prevent stroke since no data for these benefits
Indian Heart J. 2009; 61:163-172
 
171
 
Jothi Kanagalingam et al
 
 
Figure 8: Intracardiac ultrasound from the right atrium can visualize posterior left atrial wall and the esophagus. In this figure the esophagus seems to be adjacent to the atrium. The oblique sinus of the pericardial space separates these two structures and tissue changes, or effusion occurring in the oblique sinus, mandate the immediate cessation of radiofrequency energy delivery to avoid damage to the esophageal wall.
 
 
Table 3. Do’s and Don’ts with Pulmonary Vein Isolation
 

exist. The main and by far the most common reason for performing PV or other thoracic vein ablation procedures is to treat symptomatic drug refractory AF. As with any complex procedure, careful attention to details with a thorough understanding of the anatomy and electrophysiological maneuvers relevant to thoracic vein arrhythmias help optimize results.

BIBLIOGRAPHY
1. Feinberg WM, Blackshear JL, Laupacis A, et.al.: Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Archives of internal medicine 1995; 155:469-473.
2. Wolf PA, Benjamin EJ, Belanger AJ, et.al.: Secular trends in the prevalence of atrial
fibrillation: The Framingham Study. American heart journal 1996; 131:790-795.
3. Jalife J, Berenfeld O, Mansour M: Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. Cardiovascular research 2002; 54:204-216.
4. Moe GK, Rheinboldt WC, Abildskov JA: A Computer Model of Atrial Fibrillation.
American heart journal 1964; 67:200-220.
5. Pappone C, Rosanio S, Oreto G, et.al.: Circumferential radiofrequency ablation of
pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation
2000; 102:2619-2628. Table 3. Do’s and Don’ts with Pulmonary Vein Isolation

6. Haissaguerre M, Hocini M, Sanders P, et.al.: Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation 2006; 113:616-625.
7. Haissaguerre M, Jais P, Shah DC, et.al.: Spontaneous initiation of atrial fibrillation by
ectopic beats originating in the pulmonary veins. The New England journal of medicine
1998; 339:659-666.
8. Chen SA, Hsieh MH, Tai CT, et.al.: Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological
responses, and effects of radiofrequency ablation. Circulation 1999; 100:1879-1886.
9. Jais P, Haissaguerre M, Shah DC, et.al.: A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 95:572-576.
10. Kumagai K, Khrestian C, Waldo AL: Simultaneous multisite mapping studies during
induced atrial fibrillation in the sterile pericarditis model. Insights into the mechanism of
its maintenance. Circulation 1997; 95:511-521.
11. Olson TM, Alekseev AE, Moreau C, et.al.: KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nature clinical practice 2007; 4:110-116.
12. Asirvatham S: Anatomy of the vena cava: an electrophysiological perspective. In Chen SA HM, Zipes DP, ed: Thoracic vein arrhythmias: mechanisms and treatment. Malden: Blackwell Futura, 2004, pp. 54-65.
13. Oral H, Pappone C, Chugh A, et.al.: Circumferential pulmonary-vein ablation for chronic atrial fibrillation. The New England journal of medicine 2006; 354:934-941.
14. Nademanee K, McKenzie J, Kosar E, et.al.: A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. Journal of the American College of Cardiology 2004; 43:2044-2053.
15. Scherlag BJ, Hou YL, Lin J, et.al.: An acute model for atrial fibrillation arising from a peripheral atrial site: evidence for primary and secondary triggers. Journal of cardiovascular electrophysiology 2008; 19:519-527.
16. Khan MN, Jais P, Cummings J, et.al.: Pulmonary-vein isolation for atrial fibrillation in
patients with heart failure. The New England journal of medicine 2008; 359:1778-1785. 17. Van Gelder IC, Hagens VE, Bosker HA, et.al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. The New England journal of medicine 2002; 347:1834-1840.
18. Wyse DG, Waldo AL, DiMarco JP, et.al.: A comparison of rate control and rhythm control in patients with atrial fibrillation. The New England journal of medicine 2002; 347:1825- 1833.
19. Perez-Castellano N, Villacastin J, Moreno J, Rodriguez A, et.al.: Errors in pulmonary vein identification and ostia location in the absence of pulmonary vein imaging. Heart Rhythm 2005; 2:1082-1089.
20. Asirvatham SJ, Bruce CJ, Friedman PA: Advances in imaging for cardiac electrophysiology. Coronary Artery Disease 2003; 14:3-13.
21.Verma A, Marrouche NF, Natale A: Pulmonary vein antrum isolation: intracardiac
echocardiography-guided technique. Journal of Cardiovascular Electrophysiology 2004; 15:1335-1340.
22. Asirvatham SJ: Methods to identify the pulmonary vein ostium. Heart Rhythm 2005;
2:1090-1093.
23. Pappone C, Oreto G, Lamberti F, et.al.: Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation 1999; 100:1203-1208.
24. Gurevitz OT, Glikson M, Asirvatham S, et.al.: Use of advanced mapping systems to guide ablation in complex cases: experience with noncontact mapping and electroanatomic
mapping systems. Pacing Clin Electrophysiol 2005; 28:316-323.
25. Bruce CJ, Friedman PA, Narayan O, et.al.: Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation. J Interv Card Electrophysiol 2008; 22:211-219.
26. Wazni OM, Beheiry S, Fahmy T, et.al.: Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation 2007; 116:2531-2534.
27. Packer D, Asirvatham S, Seward J, et.al.: maging of the cardiac and thoracic veins. In Chen SA HM, Zipes DP, ed: Thoracic vein arrhythmias: mechanisms and treatment. Malden:: Blackwell Futura, 2004, pp. 77-98.
28. Suleiman M, Powell BD, Munger TM, Asirvatham SJ: Successful cryoablation in the
noncoronary aortic cusp for a left anteroseptal accessory pathway. J Interv Card Electrophysiol 2008; 23:205-211.
29. Asirvatham SJ: Pacing maneuvers for nonpulmonary vein sources: part II. Heart Rhythm 2007; 4:681-685.
30. Packer DL, Keelan P, Munger TM, et.al.: Clinical presentation, investigation, and
management of pulmonary vein stenosis complicating ablation for atrial fibrillation.
Circulation 2005; 111:546-554.
31. Asirvatham SJ, Friedman PA: Silent cerebral thromboembolism with left atrial ablation: a lurking danger. Journal of Cardiovascular Electrophysiology 2006; 17:8-10.
32. Lim B, Venkatachalam KL, Jahangir A, et.al.: Concurrent application of charge using a novel circuit prevents heat-related coagulum formation during radiofrequency
ablation. Journal of cardiovascular electrophysiology 2008; 19:843-850.
172
 
Indian Heart J. 2009; 61:163-172